Back

Incidence and patterns of dual antiplatelet therapy cessation among patients with peripheral arterial disease after percutaneous coronary intervention: insights the PARIS registry.

26 August 2017 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Carotid disease and stroke PCI: long-term outcome ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Sabato Sorrentino

Mater Domini Catanzaro Hospital, Catanzaro (Italy)

11 More presentations in this session

Presentation thumbnail
Doctor R. Badacz (Krakow, PL)
Abstract
Presentation thumbnail
Doctor J. Vavrova (Prague, CZ)
Abstract Slides
Presentation thumbnail
Doctor Y. Tezuka (Kyoto, JP)
Abstract
Presentation thumbnail
Doctor R. Solar (San Diego, US)
Abstract Slides
Presentation thumbnail
Doctor D. Johnsrud (Milwaukee, US)
Abstract Slides

Access the full session

Session thumbnail
Poster session 1 - Carotid disease and stroke

The Event

Event poster

ESC Congress 2017

26 August 2017 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Intense antithrombotic therapy is necessary for long-term treatment in patients with symptomatic peripheral artery disease after acute myocardial infarction and primary PCI
28 August 2020
thumbnail
Webinar
Peripheral percutaneous interventions - IC Core Curriculum 3
8 June 2022
thumbnail
Webinar
The EAPCI Journal Club: T-PASS Randomised Trial
14 November 2023
thumbnail
Congress Presentation
Dual pathway inhibitor therapy switched from dual antiplatelet therapy reduces risk of recurrent in-stent occlusion after endovascular therapy for femoropopliteal in-stent occlusion.
26 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources